Acute Respiratory Distress Syndrome (ARDS) can strike quickly, often in people already battling serious illness or injury. It happens when the lungs become inflamed and fill with fluid, making it hard for oxygen to move into the bloodstream.
Severe infections like pneumonia or sepsis most often trigger ARDS, but it can also result from trauma, aspiration, or exposure to harmful substances.
We often see ARDS develop after a significant health event that sets off widespread inflammation in the body. This inflammation damages the thin barrier between the lung’s air sacs and blood vessels, allowing fluid to leak in.
Sometimes the cause is direct, such as inhaling smoke or stomach contents. Other times it’s indirect, like when the immune system overreacts during a severe infection.
New and emerging triggers, including certain medications, vaping-related injuries, and viral infections such as COVID-19, have expanded what we know about this condition.
Acute respiratory distress syndrome (ARDS) develops when severe lung injury causes fluid to leak into the air sacs, leading to poor oxygen exchange and breathing failure. It involves widespread inflammation, reduced lung compliance, and impaired oxygen delivery to vital organs.
We define acute respiratory distress syndrome (ARDS) as a type of acute respiratory failure caused by diffuse inflammation and injury to the lungs. The Berlin Definition classifies ARDS based on the degree of oxygen impairment and imaging findings.
According to this definition, ARDS requires:
Severity is graded as:
| Category | PaO₂/FiO₂ Ratio (mmHg) | PEEP (cm H₂O) |
| Mild | 201–300 | ≥5 |
| Moderate | 101–200 | ≥5 |
| Severe | ≤100 | ≥5 |
These criteria help identify patients and guide treatment decisions in critical care.
ARDS occurs in both developed and developing regions, most often among patients in intensive care units. It affects about 10% of ICU admissions and accounts for nearly 25% of mechanically ventilated patients.
The most common triggers include sepsis, pneumonia, aspiration, and significant trauma. Viral infections such as influenza and COVID-19 have also increased global cases.
Older adults and people with chronic health conditions face higher risk. Mortality rates vary from 30% to 45%, depending on severity and underlying cause.
In ARDS, injury to the alveoli and capillary endothelium disrupts the normal barrier between air and blood. This damage allows fluid and proteins to leak into the air spaces, causing alveolar flooding and hyaline membrane formation.
Inflammation plays a central role. Activated neutrophils and macrophages release cytokines that worsen tissue injury.
The resulting diffuse alveolar damage lowers lung compliance, making the lungs stiff and more rigid to inflate. These changes cause hypoxia because oxygen cannot move efficiently into the bloodstream.
As gas exchange worsens, patients often require mechanical ventilation to maintain oxygen levels and reduce further injury.
We often see acute respiratory distress syndrome (ARDS) develop after direct injury to the lungs. These injuries damage the alveoli and surrounding tissue, leading to inflammation, fluid buildup, and poor oxygen exchange.
The most frequent causes include infection, aspiration, inhalation of harmful substances, and water exposure.
Pneumonia is the most common direct cause of ARDS. Both bacterial and viral infections can trigger widespread inflammation in the lungs.
When infection spreads through the alveoli, the immune response releases cytokines and other mediators that increase capillary permeability, allowing fluid to leak into the air sacs. Severe infectious pneumonia from pathogens such as Streptococcus pneumoniae or Staphylococcus aureus can lead to diffuse alveolar damage.
Viral infections like influenza (including H1N1) and SARS-CoV-2 have also been primary triggers. These viruses injure the alveolar–capillary barrier, causing non-cardiogenic pulmonary edema and hypoxemia.
In many cases, patients with pneumonia-related ARDS require mechanical ventilation due to stiff, fluid-filled lungs. Early recognition and targeted antimicrobial therapy are key to limiting further lung injury.
Aspiration occurs when stomach contents enter the lungs, often during vomiting, impaired consciousness, or anesthesia. The acidic gastric fluid damages the airway lining and alveoli, leading to chemical pneumonitis.
This direct irritation quickly triggers inflammation, edema, and surfactant dysfunction. The severity of injury depends on the volume and acidity of the aspirated material.
Even small amounts can cause significant harm if the fluid spreads widely through the airways. Bacterial contamination from the stomach can worsen the response, turning a chemical injury into an infectious one.
We often see aspiration-related ARDS in patients with stroke, trauma, or sedation. Preventive measures such as elevating the head of the bed and careful airway protection reduce risk.
Inhalation of smoke, chemical fumes, or toxic gases can directly injure the lungs. Substances like chlorine, ammonia, or combustion products damage the epithelial and endothelial layers of the alveoli.
The result is inflammation, fluid leakage, and impaired oxygen exchange. Thermal injury from fire or explosion can also burn the airway and cause swelling, making breathing difficult.
In some cases, the combination of heat and chemical particles leads to delayed lung injury that progresses to ARDS within 24–48 hours. We treat inhalation injuries with oxygen therapy, airway support, and removal from the toxic source.
Early management helps limit ongoing alveolar damage.
When water enters the lungs during drowning or near-drowning, it disrupts regular gas exchange and damages the alveolar surfaces. Freshwater and saltwater both wash away surfactant, causing alveolar collapse and decreased lung compliance.
The resulting hypoxia and inflammation can progress to ARDS even after initial resuscitation. Contaminated water introduces bacteria and debris, increasing the risk of infection and further lung injury.
We focus on restoring oxygenation and preventing secondary damage through careful ventilation and infection control. Monitoring for delayed respiratory failure is essential, as ARDS may develop hours after the event.
Indirect systemic triggers cause widespread inflammation that secondarily injures the lungs rather than damaging them directly. These conditions often involve severe infection, tissue injury, or immune reactions that disrupt normal blood flow and increase vascular permeability throughout the body.
Sepsis is the most common indirect cause of ARDS. It occurs when the body’s response to infection triggers widespread inflammation and damage to blood vessels.
This process allows fluid and proteins to leak into the lungs, leading to pulmonary edema and reduced oxygen exchange. In septic shock, blood pressure drops dangerously low despite fluid replacement.
Poor tissue perfusion and oxygen delivery further stress the lungs and other organs.
Key features of sepsis-related ARDS include:
The combination of infection, systemic inflammation, and circulatory collapse makes sepsis a leading cause of multi-organ failure, with the lungs often being the first affected.
Severe trauma—such as major fractures, crush injuries, or burns—can trigger ARDS even without direct chest injury. The body’s inflammatory response to tissue damage releases cytokines and other mediators into the bloodstream.
These substances increase capillary permeability and promote fluid leakage into the lungs. Massive blood loss and shock following trauma worsen oxygen delivery to tissues.
Resuscitation with large volumes of fluids or blood products can further increase lung stress.
Common trauma-related risk factors for ARDS include:
Our goal in these cases is to control bleeding, maintain perfusion, and minimize secondary lung injury from over-resuscitation.
Acute pancreatitis can cause ARDS through the release of inflammatory enzymes and mediators into the bloodstream. These substances damage distant organs, including the lungs, by increasing vascular permeability and promoting fluid accumulation.
Patients with severe pancreatitis often develop systemic inflammatory response syndrome (SIRS), which can progress to multi-organ dysfunction. Hypovolemia and shock from fluid loss into the abdominal cavity further impair lung perfusion and oxygen exchange.
We often see ARDS develop within a few days of pancreatitis onset. Early fluid management and careful monitoring of respiratory function are essential to reduce this risk.
Transfusion-related acute lung injury (TRALI) is a rare but severe reaction that can occur after plasma or blood transfusion. It results from immune interactions between donor antibodies and the recipient’s white blood cells, leading to rapid lung inflammation.
Symptoms usually appear within six hours of transfusion and include sudden shortness of breath, hypoxemia, and bilateral pulmonary infiltrates. Unlike circulatory overload, TRALI occurs without signs of fluid overload or heart failure.
Familiar transfusion sources linked to TRALI:
| Blood Product | Risk Level | Mechanism |
| Plasma | High | Donor antibodies activate neutrophils |
| Platelets | Moderate | Immune-mediated inflammation |
| Red cells | Lower | Bioactive lipids accumulate during storage |
We can reduce TRALI risk by screening donors, using plasma from male donors, and avoiding unnecessary transfusions.
We continue to identify new and rare triggers of acute respiratory distress syndrome (ARDS) as research expands. These causes often involve viral outbreaks, medication-related lung injury, and individual differences in genetic or immune responses that shape how the lungs react to injury.
Severe viral infections can directly damage the alveoli and trigger inflammation that leads to ARDS. During the H1N1 influenza and SARS outbreaks, many patients developed diffuse lung injury marked by fluid buildup and poor oxygen exchange.
These viruses increase levels of inflammatory mediators such as interleukin-6 (IL-6), which amplify immune responses and harm lung tissue. The resulting diffuse alveolar damage causes the air sacs to fill with fluid and collapse, reducing oxygen transfer.
We have also seen that viral epidemics strain healthcare systems, making early detection and ventilatory support critical. The pattern of viral ARDS often differs from bacterial or trauma-related forms, requiring careful management of oxygen levels and inflammation control.
| Common Viral Triggers | Mechanism of Injury |
| H1N1 Influenza | Direct alveolar damage, cytokine release |
| SARS | Immune dysregulation, IL-6 elevation |
| COVID-like Coronaviruses | Endothelial injury, fluid leakage |
Certain medications can cause ARDS by triggering inflammation or damaging the lung’s capillary walls. Drugs such as chemotherapy agents, statins, and some antibiotics have been linked to drug-induced lung injury.
The reaction may involve immune hypersensitivity or direct toxicity that leads to diffuse alveolar hemorrhage or pulmonary edema. Symptoms often appear days to weeks after exposure and can mimic infection.
We rely on a detailed medication history and imaging studies to identify the cause. Stopping the offending drug and providing supportive care can prevent further injury.
Key indicators:
Not all patients exposed to the same trigger develop ARDS. Differences in genetic makeup, immune regulation, and preexisting conditions influence risk.
Variants affecting inflammatory pathways, such as those regulating IL-6 or surfactant proteins, may heighten lung vulnerability. The Lung Injury Prediction Score (LIPS) helps estimate risk based on factors like sepsis, shock, or high oxygen use.
For example, individuals with higher baseline inflammation or metabolic disease may need closer monitoring when exposed to lung stressors.
Certain habits, health conditions, and medical treatments increase the likelihood of developing acute respiratory distress syndrome (ARDS). These factors often weaken lung defenses, heighten inflammation, or worsen the effects of existing illness, making the lungs more vulnerable to injury.
Regular alcohol use changes how our bodies respond to injury and infection. It can reduce the ability of the lungs to clear fluid and fight bacteria, increasing the risk of ARDS, especially during severe illness or trauma.
Chronic alcohol exposure also lowers levels of antioxidants that protect lung tissue from damage.
Cigarette smoking harms the airways and alveoli, causing long-term inflammation and structural changes. Smokers face higher rates of pneumonia and sepsis, two primary triggers of ARDS.
Even former smokers may have lingering lung injury that increases susceptibility.
When both alcohol use and smoking occur together, the combined effect on lung health is stronger. This combination can make recovery from lung injury slower and more complicated.
People with chronic health conditions such as liver disease, diabetes, or chronic obstructive pulmonary disease (COPD) have a higher risk of ARDS. These conditions can impair immune response or alter blood flow, making it harder for the lungs to recover from infection or trauma.
Obesity adds another layer of risk. Excess body weight can reduce lung volume and make ventilation more difficult.
Obesity also promotes low-grade inflammation, which may worsen the body’s reaction to infection or injury.
Patients with multiple chronic illnesses often face a combination of these challenges, increasing the chance that a severe event—like sepsis or aspiration—will lead to ARDS.
Some cases of ARDS develop inside hospitals, known as hospital-acquired ARDS. This can occur after surgery, transfusions, or infections that start during hospitalization.
Patients in intensive care units are especially at risk because of their critical condition and exposure to invasive treatments.
Ventilator-associated lung injury can also trigger or worsen ARDS. Improper ventilator settings may overinflate or collapse parts of the lung, leading to inflammation and tissue damage.
To reduce these risks, we use lung-protective ventilation strategies, limit high oxygen levels, and monitor patients closely for early signs of injury.
Preventing acute respiratory distress syndrome (ARDS) requires recognizing early signs of lung injury, minimizing harmful ventilation practices, and managing fluids carefully. In critical care, our approach focuses on identifying high-risk patients, using lung-protective ventilation, and applying evidence-based strategies to reduce complications.
We can often predict ARDS by monitoring patients with conditions such as sepsis, pneumonia, or significant trauma. Early warning signs include rising oxygen needs, diffuse lung infiltrates on imaging, and increased work of breathing.
Using risk scores and biomarkers helps us identify patients likely to develop lung injury before severe hypoxemia occurs. In the intensive care unit (ICU), continuous monitoring of oxygenation index, PaO₂/FiO₂ ratio, and respiratory mechanics supports early detection.
Prompt recognition allows us to modify treatment, such as limiting fluid overload or adjusting ventilator settings. Point-of-care ultrasound and chest CT can reveal early alveolar changes, guiding interventions that may prevent progression to full ARDS.
Mechanical ventilation supports oxygenation but can also worsen lung damage if not carefully managed. Excessive tidal volumes or high FiO₂ levels can cause overdistension, oxidative stress, and inflammation, known as ventilator-induced lung injury (VILI).
We use lung-protective ventilation strategies to minimize harm. This includes keeping tidal volumes around 6 mL/kg of predicted body weight and maintaining positive end-expiratory pressure (PEEP) to prevent alveolar collapse.
When oxygenation remains poor, prone positioning improves ventilation-perfusion matching and reduces mortality. In severe cases, extracorporeal membrane oxygenation (ECMO) may provide temporary support while the lungs recover.
Avoiding unnecessary intubation and using non-invasive ventilation when appropriate can also reduce risk.
Preventive care focuses on reducing inflammation and maintaining fluid balance. Avoiding secondary lung insults is also essential.
Conservative fluid management prevents pulmonary edema. This approach improves oxygenation.
We minimize transfusions and control infection promptly. Using antibiotics judiciously helps limit systemic inflammation.
Sedation protocols that allow spontaneous breathing may reduce ventilator days. They can also decrease lung stress.
In high-risk surgical or trauma patients, careful monitoring is essential. Early intervention with lung-protective ventilation lowers the chance of ARDS.
Team-based care in the ICU coordinates physicians, nurses, and respiratory therapists. This ensures consistent application of preventive strategies.
Acute Respiratory Distress Syndrome (ARDS) can develop suddenly, often following severe infections, trauma, or inflammation. Recognizing its causes—whether direct lung injury like pneumonia and aspiration, or indirect triggers such as sepsis or pancreatitis—is key to prevention and early intervention. Understanding how the lungs respond to injury empowers patients and caregivers to take fast, informed action when symptoms arise. Prevention also means protecting your lungs every day—by avoiding smoking, managing chronic illnesses, and maintaining follow-up with respiratory specialists. With awareness and proactive medical guidance, many cases of ARDS can be minimized or avoided altogether.
Stay ahead of lung complications with expert pulmonary care.
At Gwinnett Pulmonary & Sleep, our board-certified pulmonologists specialize in diagnosing and managing conditions that can lead to ARDS. Through advanced monitoring, preventive care, and patient education, we help protect your lung health and improve long-term outcomes.
Book your appointment today at gwinnettlung.com or call 770-995-0630 to schedule your consultation.
Plugin powered by Kapsule Corp
